Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

XMReality Year-end report 2023, Group overview

The total order intake for the year increased by 8 percent for 2023 compared to 2022. As a result of strong customer growth, XMReality now has more than 150 customers. Net sales increased by 5 percent in 2023 compared to 2022, while the quarter was unchanged compared to the same period last year. The company has significantly reduced costs during the quarter and will enter 2024 with a cost mass that is approximately SEK 20 million lower on an annual basis. For the full year 2023, costs were 10 percent lower compared to 2022, and for the quarter, costs were down 6 percent compared to the last

Pharmacolog investigates the possibilities for a new business direction

Within the framework of the Board's established strategy, a significant milestone was recently communicated with the sale of Druglog to Raysearch Laboratories AB. Together with the cost-saving measures implemented by the Board, the financial risk is reduced to the extent that the company's position can pave the way for a new business direction. The Board intends to immediately investigate the conditions for a new business direction, which may include the acquisition of niche and profitable companies in the life science sector.The work of looking for and identifying potential acquisitions

Crunchfish publishes year-end report 2023

Crunchfish is pleased to publish the company’s year-end report for 2023. CEO Joachim Samuelsson comments that focus is on online payments going forward. To clear the books for 2024 Crunchfish has decided to write-off the gesture business. A webinar with an interview of Crunchfish CEO will be live streamed at 09.00 CET / 13.30 IST today.2023-10-01 2022-10-01 2023-01-01 2022-01-01  2023-12-31 2022-12-31 2023-12-31 2022-12-31Net sales (SEK) 333,351 30,462 987,834 6,186,821Loss before tax (SEK) -26,815,005 -9,648,772

MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2023

“The clinical efficacy of fostrox in combination with Lenvima continues to improve with median time to progression having increased to over 6 months”October – December Financial summary for the quarter · Net turnover amounted to SEK 4.4 (2.3) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -20.1(-17.9) million. Basic and diluted earnings per share amounted to SEK -0.28 (-0.32) and SEK -0.28 (-0.32) respectively. · Cash flow from operating activities amounted to SEK -4.6 (-24.7) million. · Cash and cash equivalents at the

ORGANOCLICK AB (PUBL) PUBLISH YEAR END REPORT FOR 2023

During the last quarter of the year, sales remained strong with growth across all business units. Overall, sales grew by 29 percent to MSEK 27.9 (21.6). Our operating profit/loss improved to MSEK -6.1 (-19.7) thanks to the increasing sales and lower costs. Cash flow from operating activities strengthened significantly to MSEK 6.7 (0.1).Translation from CEO Mårten Hellbergs comments to the Interim Report. Q4, 1 October - 31 December 2023 The Group's result in Q4 2023 compared with Q4 2022 » Net revenue amounted to SEK 27.91 (21.63) million » The gross margin amounted to 18.4 (-21.

Long-term incentive plan based established for Raute's senior management and selected key persons

RAUTE CORPORATION STOCK EXCHANGE RELEASE 15 FEBRUARY 2024 at 9:15 a.m.   LONG-TERM INCENTIVE PLAN ESTABLISHED FOR RAUTE’S SENIOR MANAGEMENT AND SELECTED KEY PERSONS   Raute Corporation’s Board of Directors has decided on the commencement of a long-term incentive plan for the Group’s senior management and selected key persons. The decision includes a Performance Share Plan (“PSP”) as the main structure and a restricted Share Plan (“RSP”) as a complementary structure.   The purpose of the plan is to align the objectives of the owners and management in order to develop the

VTT explores how to make communications smoother with quantum computing – 6G era challenges connectivity

Press release 15 February, 2024 The growth in the number of information network users frequently leads to congestion, causing delays and disruptions of service for users. At the same time, the increasing complexity of networks and their applications is challenging network control and management. VTT, one of Europe's leading research institutions has launched a project to investigate how quantum computing can be used to solve increasing network problems.As more people use network resources simultaneously, for example during large events, wireless networks are challenged with congestion

Proposals of the Board of Directors of Tietoevry Corporation to the Annual General Meeting to be held on 13 March 2024

Tietoevry Corporation     STOCK EXCHANGE RELEASE     15 February 2024   9.05 a.m. EET The Annual General Meeting (the "AGM") of Shareholders of Tietoevry Corporation (the "company") shall be held on Wednesday, 13 March 2024 at 4 p.m. (Finnish time) at the company’s premises, address Keilalahdentie 2-4, 02150 Espoo, Finland. The company will publish the notice of the AGM on 15 February 2024, which will include more detailed information on participation in and voting at the meeting. The registration period and advance voting period for the AGM are planned to commence on 15 February 2024

Dignitana AB Publishes Q4 2023 Interim Report

Positive EBITDA, continued growth and high margin Financial highlights Q4 2023 · Net sales amounted to 22.2 MSEK (18.6), an increase of 19 percent over the same period in 2022. · Operating result amounted to-3.1 MSEK (-3.6). · Net result after financial items amounted to-3.7 MSEK (-3.7). · EBITDA for the Third Quarter is positive at 674 TSEK (-119). · Earnings per share were-0.05 SEK (-0.06). · Cash Balance amounted to 7.0 MSEK (6.7). · Average Daily Treatment Revenue (ADTR)* was 237 TSEK (203), an increase of 17 percent over the same period in 2022 Financial

Alisa Bank Plc’s Financial Statements Bulletin 2023

ALISA BANK PLC STOCK EXCHANGE RELEASE 15.2.2024 AT 09.00 EETPROFITABLE RESULT  January-December 2023 in brief · January-December result before non-recurring items and taxes was EUR 0.8 million (-7.8). The result before taxes was EUR 0.3 million (-9.7). · Net interest income increased from last year and was EUR 14.8 million (9.1). Net interest income increased mainly due to the increase in market interest rates and the increase in the loan portfolio. · Total operating income EUR 16.7 million increased clearly compared to the previous year (10.2). · Realized and expected

Statement from AcadeMedia's board regarding the change of ownership

Mellby Gård, who is the largest owner of AcadeMedia since 2016, has announced that it will sell its shares to the Akelius Foundation (trough Akelius Apartments Ltd). The Akelius Foundation will thus become the new main owner of AcadeMedia when the relevant authorities have approved the transaction. AcadeMedia's board makes this statement regarding the company getting a new main owner: · AcadeMedia's strategy is laid down in Roadmap 2030. It states that continued international expansion is important, Roadmap 2030 also has a strong focus on educational quality and sustainability. ·

AQ Group AB (publ): Year-end report 2023

Fourth quarter, October-December 2023 in brief   · Strong cash flow and the board proposes a doubled dividend · Net sales increased by 12% to SEK 2,221 m (1,974) · Operating profit (EBIT) increased by 30% to SEK 193 m (148) · Profit before tax (EBT) increased by 33% to SEK 182 m (137) · Profit margin before tax (EBT %) was 8.2% (6.9) · Profit after tax amounted to SEK 134 m (134) · Cash flow from operating activities amounted to SEK 239 m (140) · Earnings per share before dilution amounted to SEK 7.32 (7.27)   Full year 2023 in brief   · Net sales

Year-end report January-December 2023

Our best year - focus on continued growth October – December 2023     · Net sales totaled SEK 27,306 (25,741) thousand, with a growth rate of 6%. Growth is 4%, adjusted for currency effects. · Operating profit before depreciation and amortization (EBITDA) totaled SEK 3,615 (-5,915) thousand. Adjusted for non-recurring costs of moving to new premises, EBITDA is SEK 3,721 thousand. · Operating profit (EBIT) totaled SEK 355 (-7,043) thousand. Adjusted for non-recurring costs for moving to new premises, EBIT is SEK 760 thousand. · Profit for the period totaled SEK -422 (-7,508)

Directorate Change and Director Declaration

For immediate release                                                                                            15 February 2024 DIRECTORATE CHANGE AND DIRECTOR DECLARATION Keller Group plc, the world’s largest geotechnical specialist contractor, today announces that independent Non-Executive Director and Chair of the Remuneration Committee, Eva Lindqvist, has decided to retire from the Board at the conclusion of the Company’s Annual General Meeting (“AGM”) to be held on 15 May 2024, having served on the Board for seven years. Annette Kelleher, independent Non-Executive

ContextVision AB: Year-end report 2023 – Underlying growth and scaling up the business

Q4 Highlights · New advanced X-ray product Altumira™ Plus with scatter correction released · Participation in world’s largest medical imaging conference, Radiological Society of North America (RSNA) · Increasing interest from customers and OEMs in our products · Strategic investments in Point of Care Ultrasound (POCUS), R&D and Quality Management Q4 Financial Data · Record Q4 Net Sales of 33.2 MSEK (32.6) · Operating result of 3.2 MSEK (9.1) · EBITDA of 5.2 MSEK (11.0) · Dividend payout of 11.6 MSEK · Earnings per share of 0.04 SEK (0.10) Full Year

Notice to the Annual General Meeting of Kojamo plc

Kojamo plc Stock Exchange Release, 15 February 2024 at 9.00 a.m. EETNotice to the Annual General Meeting of Kojamo plc Notice is given to the shareholders of Kojamo plc to participate in the Annual General Meeting to be held on Thursday 14 March 2024 at 10.00 a.m. (EET) in Pikku-Finlandia at Karamzininranta 4, Helsinki, Finland. The reception of participants and the distribution of ballots will commence at the meeting venue at 9.00 a.m. (EET). Shareholders and their proxy representatives may also exercise voting rights by voting in advance. Instructions for advance voting are presented

Frida Norrbom Sams and Mark Williamson proposed as new members of the board of directors of Concentric AB

The nomination committee of Concentric AB proposes that Frida Norrbom Sams and Mark Williamson are elected as new members of the board of directors at the annual general meeting on April 18, 2024. The nomination committee further proposes that Anders Nielsen, Claes Magnus Åkesson, Karin Gunnarsson, Petra Sundström, Martin Sköld and Joachim Rosenberg are re-elected. The current board member Susanna Schneeberger has informed the nomination committee that she declines re-election. The nomination committee’s proposal means the board will consist of eight members elected by the general

Implantica’s RefluxStop™ now available in Munich

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStop™ procedures completed at Artemed Klinikum München Süd in Munich, Germany.Prof. Thomas Mussack, Chief Physician and Medical Director of the Department of Surgery at Artemed Klinikum München Süd, performed two successful RefluxStop™ procedures to treat severe GERD. Today, both patients have returned to eating normally and are well treated. Prof. Mussack says, “I appreciate how RefluxStop™ restores the body’s natural anatomy to solve the root problem of

Polygiene Group AB (publ.) Interim Report October 1 – December 31, 2023

SIGNS OF RECOVERY AND POSITIVE MARKET SIGNALS Net sales for the quarter amounted to MSEK 30.9 (40.0), down 23 % from the same period in 2022. This period saw a solid gross margin of 70.6 (64.9) %. Operating profit before interest, taxes, depreciation, and amortization (EBITDA) came to MSEK -3.4 (-1.8) million, including one-off costs of MSEK 3.7. Cash flow was negative at MSEK -2.3 million (-4.1 adjusted for foreign currency effects), and cash and cash equivalents totaled MSEK 44.1.Financial development during the quarter · Net sales amounted to MSEK 30.9 (40.0). There is an

Esmaeilzadeh Holding publishes net asset value as of 31 January 2024

As of 31 January 2024, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 7.14 billion (SEK 7.16 billion as of 31 December 2023), corresponding to a net asset value per share of SEK 9,268 (SEK 9,294 as of 31 December 2023).[1] For further information, please contact: Mikael Ericson, CEO mikael.ericson@ehab.group Nils Fredrik Lagerstrand, General Counsel & Deputy CEO +46 720 90 26 99, nilsfredrik@ehab.group The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on 15 February 2024. About

Motion to 2024 Annual General Meeting in JM AB regarding Chair and Board Members

The Nomination Committee of JM AB has decided to propose the following to the 2024 Annual General Meeting regarding the composition of the Board of Directors.Number of Board Members: Seven ordinary Members.   The Nomination Committee proposes the re-election of Fredrik Persson as Chair of the Board. The Nomination Committee furthermore proposes the re-election of Members Stefan Björkman, Kerstin Gillsbro, Jenny Larsson, Olav Line, Thomas Thuresson and the new-election of Liia Nõu. Camilla Krogh has declined re-election. Liia Nõu, born in 1965, is currently the CEO of Pandox. Before

Year-end report 1 January – 31 December 2023

January – December · Revenue amounted to SEK 589.7 million (501.6), a year-on-year increase of 18 per cent. · Net operating income for the period amounted to SEK 337.2 million (278.9), a year-on-year increase of 21 per cent. · Profit from property management amounted to SEK 124.2 million (113.4), a year-on-year increase of 10 per cent. · Changes in the value of investment properties amounted to SEK -439.9 million (-25.7) and changes in the value of derivatives to SEK -139.8 million (95.9). · Earnings totalled SEK -381.5 million (125.1), corresponding to SEK -2.91 per share (

Interim Report January – December 2023: Continued sustainable and profitable expansion and a strong financial position

Our growth journey continued during the fourth quarter. SLP can report another strong quarter driven by continued acquisitions, new construction projects, and new and extended rental agreements with satisfied tenants.· Rental income increased by 42%, amounting to SEK 585 m (411). · Net operating income increased by 49%, amounting to SEK 487 m (327). · Profit from property management increased by 36% and amounted to SEK 303 m (222). · Earnings per share after dilution amounted to SEK 1.55 (2.39). · Net asset value (NAV) per share after dilution increased by 15% in the

There are no items matching the current filter
There are no more items matching the current filter
Back to top